Skip to main content

Market Overview

68 Biggest Movers From Yesterday

68 Biggest Movers From Yesterday


  • Prevail Therapeutics Inc. (NASDAQ: PRVL) shares jumped 82% to close at $22.75 on Tuesday after the company agreed to be acquired by Eli Lilly (NYSE: LLY).
  • BioCardia, Inc. (NASDAQ: BCDA) jumped 49.6% to close at $6.70. BioCardia reported a 1.789 million share registered direct offering priced at $4.75 per share. The company yesterday said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Trial.
  • MicroVision, Inc. (NASDAQ: MVIS) climbed 34.5% to close at $4.21.
  • Elys Game Technology, Corp. (NASDAQ: ELYS) jumped 29% to close at $4.00. Elys Game Technology’s CEO Michelle Ciavarella reported the purchase of 58,000 shares at an average price of $3.02 per share in Form 4 filing on Monday.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) gained 27.6% to close at $7.07 amid recent strength in Bitcoin prices.
  • Arvinas, Inc. (NASDAQ: ARVN) climbed 27.2% to close at $74.25 as various analysts raised price target on the stock. Arvinas reported a proposed offering of $250 million of common stock.
  • Apartment Income REIT Corp. (NYSE: AIRC) gained 26.5% to close at $37.95.
  • Sensus Healthcare, Inc. (NASDAQ: SRTS) surged 26.4% to close at $4.50. Sensus Healthcare reported an exclusive distribution deal with Ekpac Healthcare to market the company’s SRT-100 Systems in China and Hong Kong.
  • Solid Biosciences Inc. (NASDAQ: SLDB) shares gained 23.4% to close at $5.91. Solid Biosciences, last week, announced a $90 million private placement of 24.3 million shares at $3.70 per share.
  • Bridgetown Holdings Limited (NASDAQ: BTWN) gained 22.6% to close at $13.58.
  • Polar Power, Inc. (NASDAQ: POLA) climbed 20.3% to close at $4.68.
  • OncoCyte Corporation (NYSE: OCX) rose 19.3% to close at $2.53. Burning Rock Biotech announced a licensing agreement with OncoCyte to bring the latter's DetermaRx, a risk stratification test for early stage lung cancer patients, to China.
  • VivoPower International PLC (NASDAQ: VVPR) gained 19.2% to close at $7.65.
  • Vuzix Corporation (NASDAQ: VUZI) rose 18.8% to close at $5.74 after the company announced Plug Power is using its M400 smart glasses for remote training and onboarding.
  • PFSweb, Inc. (NASDAQ: PFSW) gained 18.3% to close at $7.23.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) climbed 17.8% to close at $63.25 as the company reported changes to its senior management team.
  • Retractable Technologies, Inc. (NYSE: RVP) gained 17.5% to close at $15.00.
  • Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) rose 17.2% to close at $3.13.
  • ReneSola Ltd (NYSE: SOL) gained 17.2% to close at $8.18.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) surged 17% to close at $51.17. TG Therapeutics, on Monday, reported a $200 million common stock offering.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) gained 17% to close at $6.25 after the company reported a multi-year deal with NFL's Philadelphia Eagles to become NFL's first esports tournament club provider.
  • Aclaris Therapeutics, Inc. (NASDAQ: ACRS) rose 16.8% to close at $4.59.
  • Sequential Brands Group, Inc. (NASDAQ: SQBG) gained 16.6% to close at $19.23. Sequential Brands Group, earlier during the month, announced a relaunch of a broad review of strategic alternatives.
  • TransMedics Group, Inc. (NASDAQ: TMDX) rose 16.3% to close at $17.90.
  • Fuel Tech, Inc. (NASDAQ: FTEK) gained 16.2% to close at $4.15.
  • Daqo New Energy Corp. (NYSE: DQ) shares surged 15.9% to close at $55.99. Daqo New Energy, on Monday, announced a long-term supply agreement with Trina Solar.
  • Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 15.8% to close at $10.90 on continued volatility following Monday strength.
  • iRhythm Technologies, Inc. (NASDAQ: IRTC) gained 15.7% to close at $217.52 as the company reported the retirement of its President and CEO, Kevin King.
  • Sio Gene Therapies, Inc. (NASDAQ: SIOX) climbed 15.5% to close at $2.84. Sio Gene Therapies, earlier during the month, said first patient was dosed in high-dose cohort of AXO-AAV-GM1 clinical trial in patients with GM1 Gangliosidosis.
  • Anavex Life Sciences Corp. (NASDAQ: AVXL) gained 15.4% to close at $5.99 after the company reported the results from its U.S. Phase 2 placebo-controlled trial of ANAVEX®2-73 in adult female patients with Rett syndrome met the primary and secondary endpoints.
  • Immutep Limited (NASDAQ: IMMP) gained 15.4% to close at $3.45 after the company issued an update on 6 clinical trials.
  • Nisun International Enterprise Development Group Co., Ltd (NASDAQ: NISN) surged 15.1% to close at $18.06.
  • NeuroMetrix, Inc. (NASDAQ: NURO) gained 15.1% to close at $2.82. The company was granted U.S. patent titled ‘Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement.’
  • Qualigen Therapeutics, Inc. (NASDAQ: QLGN) surged 15% to close at $4.07 as the company reported issuance of US patent for expanded applications of ALAN anticancer platform technology.
  • SG Blocks, Inc. (NASDAQ: SGBX) gained 14.9% to close at $3.86. SG Blocks said it expects FY21 gross revenue of $20 million.
  • Baidu, Inc. (NASDAQ: BIDU) shares surged 13.8% to close at $185.50 following reports of the Chinese search giant's interest in the lucrative field of electric vehicle manufacturing.
  • The RealReal, Inc. (NASDAQ: REAL) rose 12.9% to close at $17.30 after Piper Sandler initiated coverage on the company's stock with an Overweight rating and announced a $19 price target.
  • Lydall, Inc. (NYSE: LDL) shares gained 12% to close at $33.00.
  • Mid-Con Energy Partners, LP (NASDAQ: MCEP) rose 11.1% to close at $4.20 after climbing over 25% on Monday.
  • SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) climbed 8.5% to close at $7.26 after dropping 20% on Monday. SELLAS Life Sciences Group, last week, reported follow-up data from a randomized Phase 2 VADIS trial of Nelipepimut-S in woman with ductal carcinoma in-situ of the breast.
  • Socket Mobile, Inc. (NASDAQ: SCKT) shares gained 8.4% to close at $3.10. Socket Mobile shares gained around 8% on Monday after the company announced it received a notice of forgiveness from Western Alliance Bank for the $1.06 million PPP loan.
  • Celsion Corporation (NASDAQ: CLSN) gained 7.5% to close at $0.7097 after declining 6% on Monday.
  • Immuron Limited (NASDAQ: IMRN) gained 7% to close at $7.49 after the company reported a research services deal with Monash University to advance SARS-CoV-2 findings.
  • NIO Limited (NYSE: NIO) gained 6.2% to close at $43.50 amid volatility in EV names. The stock dipped last week following the announcement of a common stock offering.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers


  • Apartment Investment and Management Company (NYSE: AIV) shares tumbled 86.5% to close at $5.04 on Tuesday after the company announced it completed the separation of its businesses, making Apartment Income REIT a separate, publicly-traded company. The company is also being replaced by Tesla in the S&P 500.
  • CooTek (Cayman) Inc. (NYSE: CTK) fell 31.4% to close at $4.34 after the company reported results for the third quarter.
  • China Liberal Education Holdings Limited (NASDAQ: CLEU) tumbled 28.9% to close at $4.23. China Liberal Education reported sales of 46,626 copies of self-developed textbooks published by Fudan University Press.
  • MIND Technology, Inc. (NASDAQ: MIND) fell 28.3% to close at $1.77. MIND Technology, earlier during the month, posted a Q3 loss.
  • Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) declined 22.8% to close at $18.54 after the company priced its previously announced underwritten public offering of 3.75 million shares of its common stock at $20 per share for raising gross proceeds of $75 million.
  • Loop Industries, Inc. (NASDAQ: LOOP) fell 22.4% to close at $7.24.
  • Precigen, Inc. (NASDAQ: PGEN) dropped 22.3% to close at $7.17. Precigen, last week, presented new data supporting safety, clinical activity, expansion, persistence of PRGN-3006 UltraCAR-T at ASH.
  • Mesoblast Limited (NASDAQ: MESO) shares fell 19.7% to close at $13.57 as the company announced mixed top-line results from the DREAM-HF Phase 3 study of its allogeneic cell therapy rexlemestrocel-L in 537 patients with advanced chronic heart failure.
  • Luminar Technologies Inc (NASDAQ: LAZR) shares declined 17.6% to close at $22.87.
  • Cellectis S.A. (NASDAQ: CLLS) dipped 17.1% to close at $25.86 after the company reported a $100 million ADS offering.
  • Meten EdtechX Education Group Ltd. (NASDAQ: METX) fell 14.6% to close at $1.87.
  • Yalla Group Limited (NASDAQ: YALA) dipped 13.5% to close at $16.15.
  • Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) fell 13.3% to close at $36.00.
  • Dada Nexus Limited (NASDAQ: DADA) dropped 13.1% to close at $37.02.
  • Monaker Group, Inc. (NASDAQ: MKGI) fell 12.2% to close at $2.66.
  • Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) declined 11.2% to close at $10.74. Hancock Jaffe, on Monday, reported one year follow-up data on eleventh VenoValve patient.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) fell 10.9% to close at $7.78 after surging over 36% on Monday.
  • AMC Entertainment Holdings, Inc. (NYSE: AMC) dropped 10.3% to close at $2.86 amid continued liquidity and bankruptcy concerns.
  • Humanigen, Inc. (NASDAQ: HGEN) shares fell 9.9% to close at $10.78 after gaining over 26% on Monday. Humanigen, last month, reported the establishment of Humanigen Australia Proprietary Limited.
  • Creative Realities, Inc. (NASDAQ: CREX) declined 9.7% to close at $1.21 after gaining over 16% on Monday.
  • Synlogic, Inc. (NASDAQ: SYBX) fell 9.5% to close at $2.30. Synlogic shares rose 13% on Monday after the company announced plans to advance its cancer treatment into the combination therapy stage of its phase 1 trial.
  • Torchlight Energy Resources, Inc. (NASDAQ: TRCH) fell 9.5% to close at $0.5591 after declining over 18% on Monday.
  • Phoenix Tree Holdings Limited (NYSE: DNK) fell 9.2% to close at $2.87.
  • Blonder Tongue Laboratories, Inc. (NYSE: BDR) fell 8.3% to close at $1.33 after climbing over 18% on Monday. Blonder Tongue, last week, reported the receipt of noncompliance notice from NYSE American.

Related Articles (ACRS + AIRC)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at